Full access
Government News
Published Online: 19 November 2004

Some Prescriptions May Get Closer Monitoring

Publication: Psychiatric News
Volume 39, Number 22
https://doi.org/10.1176/pn.39.22.00390014a
Track CitationsAdd to favorites
The House of Representatives, before it recessed last month, passed a bill that would establish a national reporting database for controlled substances.
The bill covers medications in Schedules 2 through 4 of the Controlled Substances Act (CSA). The CSA places all substances that are federally regulated into one of five schedules. The placement depends on the substance's medicinal value, harmfulness, and potential for abuse or addiction. Schedule 1 drugs are considered the most dangerous, with no recognized medical use, while Schedule 5 is reserved for the least dangerous drugs, according to the CSA legislation.
Rep. Edward Whitfield (R-Ky.), the bill's sponsor, said last year when he introduced the bill that it was intended to keep drug addicts from“ doctor shopping” and to prevent prescription mix-ups, according to an October 1 article in iHealthBeat.
The National All Schedules Prescription Electronic Reporting Act of 2004 would require pharmacists to file a report within one week of dispensing a controlled substance.
The report is to include the name of the person who prescribed the drug, contact information for the person who received the drug, the drug's national drug code number, and the number of refills ordered.
Doctors and other clinicians would have access to the database information under certain circumstances, which would be determined by the secretary of Health and Human Services (HHS).
The legislation also calls for HHS to establish a uniform electronic format for reporting and sharing drug data.
The bill, HR 3015, authorizes federal appropriation of $25 million each in Fiscal 2006 and 2007, and $15 million in each of the following three fiscal years to help pay for the databases.
The bill has been sent to the Senate, where it awaits action.
The National All Schedules Prescription Electronic Reporting Act of 2004 can be accessed online at<http://thomas.loc.gov> by searching on the bill name or number, HR 3015.
The Controlled Substances Act is posted online at<www.usdoj.gov/dea/agency/csa.htm>.▪

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 39 • Number 22 • November 19, 2004
Pages: 14 - 17

History

Published online: 19 November 2004
Published in print: November 19, 2004

Notes

Congress is considering a bill that would mandate closer monitoring of prescriptions for controlled substances.

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.